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Abstract
We recently reported that the oxidized avidin, named AvidinOXH, resides for weeks within injected tissues as a consequence
of the formation of Schiff’s bases between its aldehyde groups and tissue protein amino groups. We also showed, in a
mouse pre-clinical model, the usefulness of AvidinOX for the delivery of radiolabeled biotin to inoperable tumors. Taking
into account that AvidinOX is the first oxidized glycoprotein known to chemically link to injected tissues, we tested in the
mouse a panel of additional oxidized glycoproteins, with the aim of investigating the phenomenon. We produced oxidized
ovalbumin and mannosylated streptavidin which share with avidin glycosylation pattern and tetrameric structure,
respectively and found that neither of them linked significantly to cells in vitro nor to injected tissues in vivo, despite the
presence of functional aldehyde groups. The study, extended to additional oxidized glycoproteins, showed that the in vivo
chemical conjugation is a distinctive property of the oxidized avidin. Relevance of the high cationic charge of avidin into the
stable linkage of AvidinOX to tissues is demonstrated as the oxidized acetylated avidin lost the property. Plasmon resonance
on matrix proteins and cellular impedance analyses showed in vitro that avidin exhibits a peculiar interaction with proteins
and cells that allows the formation of highly stable Schiff’s bases, after oxidation.
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Introduction
We recently reported that a ligand-protected oxidized avidin
(OXavidinHABA, AvidinOXH) exhibits the property to reside within
injected tissues for weeks thus constituting a stable artificial receptor
for biotinylated therapeutics [1;2]. We also showed, in a mouse
model,theuseofthis product forthetargeting ofradiolabeledbiotin
to inoperable neoplastic tissues, resulting in eradication of cancer
lesions [3]. Tissue residence of AvidinOX was found to be
dependent on the formation of Schiff’s bases between avidin
aldehyde groups, generated by sodium periodate oxidation of the
sugar pyranosidic rings, and tissue protein amino groups. In fact,
conversion of aldehyde groups to semicarbazones by reaction with
semicarbazide resulted in reduced tissue residence [1]. Oxidation of
glycoproteins with sodium periodate is the first step of a laboratory
procedure used for decades to generate conjugates in vitro [4;5]. For
example, to produce enzyme linked immunoglobulins, aldehyde
groups derived from oxidation of the sugar pyranosidic rings of a
given antidody, arecondensedwiththe aminogroups of an enzyme.
The condensation reaction, resulting in the formation of Schiff’s
base, must be performed at neutral/basic pH because at acidic pH
amino groups are in the inert protonated NH3
+ status. However,
while the formation of stable adducts between oxidized sugars and
protein amino groups is a common event in vivo, leading to protein
glycation [6], AvidinOX is the first example of adduct formation
between an oxidized glycoprotein, which is formulated at acidic pH
to prevent homologous reaction, and tissue proteins.
The aim of the present work was to investigate such in vivo
chemical conjugation and we included in the study several
oxidized glycoproteins. Surprisingly, we found that the stable
linkage to the injected tissues is a distinctive property of AvidinOX
being not exhibited by the other oxidized glycoproteins tested.
Our analysis demonstrates that the peculiar electrostatic interac-
tion of the highly cationic avidin with negatively charged
biological substrates is an essential condition for the formation of
Schiff’s bases of the oxidized derivative in vivo.
Results
Tissue residence and cell binding of oxidized ovalbumin
1AvidinOX is the first glycoprotein described to chemically link
to injected tissues. Therefore, to evaluate the extent of the
phenomenon, we evaluated other oxidized glycoproteins. We
started with the oxidation of the chicken ovalbumin [7] that, as
chicken avidin, is extracted from the egg white and exhibits the
same glycosylation pattern (high mannose and N-acetylglucosa-
mine hybrid sugars in bi-antennary bisected and non-bisected
structures). However, avidin is a glycoprotein with an isolectric
point (pI) .10 and a 66 kDa tetrameric structure [8] while
ovalbumin is a monomeric protein of 45 kDa with pI 4.7.
Oxidation with 20 mM sodium periodate of
125Iodine labeled
avidin and ovalbumin, produced 16.5 and 12.6 aldehyde groups/
glycoprotein, respectively. Radiolabeled avidin and ovalbumin, in
their native and oxidized forms, were intramuscularly injected in
PLoS ONE | www.plosone.org 1 June 2011 | Volume 6 | Issue 6 | e21075mice and surprisingly, it was found that, 24 hours after injection,
the amount of oxidized avidin in the tissue was about 20 times that
of oxidized ovalbumin (Fig. 1A). Notably, native avidin persisted
longer in the limb muscle than native ovalbumin, thus suggesting
an intrinsic property of the former to interact with tissues.
To further investigate this result we evaluated by cytofluori-
metry the cell binding of oxidized avidin and ovalbumin. Human
prostate carcinoma PC3 and mouse fibroblast NIH-3T3 cells were
selected as model cell lines. Consistently with in vivo data, only
native avidin but not native ovalbumin exhibited a non specific
binding to cell membranes of both cell lines and this binding was
significantly increased after oxidation while binding of oxidized
ovalbumin was barely detectable (Fig. 1B).
Reactivity of the aldehydes of oxidized ovalbumin was
confirmed by chromatography that showed the formation of
adducts with the dye pararosaniline (Schiff’s reagent) (Fig. 1C).
Both in vivo and in vitro data indicated that oxidized avidin stably
binds tissues and cells while oxidized ovalbumin does not despite
functional aldehydes.
Tissue residence and cell binding of oxidized
glycosylated streptavidin
Trying to explain the previous unexpected result, we assessed
whether the spatial position of aldehydes on the tetrameric
structure of avidin might account for its interaction with tissue
protein amino groups leading to the formation of Schiff’s bases.
Figure 1. Tissue residence and in vitro cell binding of native and oxidized avidin and ovalbumin. A, Avidin and ovalbumin were
125I-
labeled and then oxidized with sodium periodate. After purification, native and oxidized samples were diluted at 3.0 mg/ml in sodium acetate pH 5.5
and 15 ml were injected intramuscularly in one hind limb of mice. After 24 hours, the mice were sacrificed and treated limbs collected, weighed and
counted in a gamma counter. Data are expressed as the % of injected dose/100 mg (% ID/100 mg) of tissue. Each point is the average of 5 mice. Bars
represent standard deviation. Statistical analysis by Student’s t test. ***p,0.001. B, Cytofluorimetry of the binding of native and oxidized avidin and
ovalbumin to human prostate carcinoma PC3 and mouse fibroblast NIH-3T3 cells. Cells were incubated with 150 mM of either native or oxidized
avidin or ovalbumin and binding revealed by specific primary antibodies as detailed in Materials and Methods. Gray peaks represent background
(second antibody, only). Thin and bold lines, native and oxidized glycoproteins, respectively. C, Size exclusion chromatography on Bio-Sep-SEC-S
3000 (Phenomenex) of ovalbumin (left panel) or oxidized ovalbumin (right panel) after reaction with pararosaniline dye (Schiff’s reagent, Sigma-
Aldrich, USA). Baseline absorbance of dye at 280 and 550 nm (yellow and green lines, respectively) and ovalbumin or oxidized ovalbumin absorbance
peaks at 280 nm (blue) and 550 nm (red). Red peak in the right panel indicates the formation of Schiff’s bases between oxidized ovalbumin and the
pararosaniline dye thus confirming the presence of functional aldehydes on oxidized but not native (left panel) ovalbumin.
doi:10.1371/journal.pone.0021075.g001
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a tetrameric organization homologous to that of avidin as
previously shown by superimposition of avidin and streptavidin
crystallographic structures [10]. Taking into account the high
mannose glycosylation pattern of avidin, streptavidin was
chemically conjugated to mannose obtaining two derivatives with
26 % (low mannose) and 60 % (high mannose) mannosylated
amino groups, respectively. Cytofluorimetry of PC3 and NIH-3T3
cells showed that the binding of low mannose streptavidin and
oxidized low mannose streptavidin (8.5 aldehydes/glycoprotein) to
PC3 and NIH-3T3 cells after 1 hour at 4uC was lower than native
and oxidized avidin, respectively (Fig. 2A). Similar results were
obtained with oxidized high mannose streptavidin exhibiting 11.1
aldehydes/glycoprotein (data not shown).
To evaluate the residence in vivo, both low and high mannose
125I-streptavidin were oxidized after saturation with HABA, as
previously described for avidin [1]. When streptavidin and low
and high mannose streptavidin were injected intramuscularly in
one hind limb of mice, 0.8560.54, 6.4260.54 and 9.6163.36 %
ID/100 mg of tissue were found after 24 hours, respectively,
Figure 2. In vitro cell binding, in vivo tissue residence and biotin uptake of chemically glycosylated and oxidized streptavidin. A,
Binding of streptavidin (SA), low mannose streptavidin (GlySA) and oxidized derivative (OxGlySA) to human prostate carcinoma PC3 and mouse
fibroblast NIH-3T3 cells was compared to avidin and AvidinOX. Cells were incubated with 150 mM of either native or oxidized glycoproteins at +4uC
and binding revealed by cytofluorimetry with specific primary antibodies as detailed in Materials and Methods. Gray peaks represent background
(second antibody, only). Thin and bold lines, native and oxidized glycoproteins, respectively. B, Avidin, streptavidin, low and high mannose
streptavidin (corresponding to 26 and 60 % of mannosylated amino groups, respectively) were
125I-labeled and oxidized with sodium periodate as
detailed in Materials and Methods. All samples in their native and oxidized form were diluted to 3.0 mg/ml in sodium acetate pH 5.5 and 15 ml were
injected intramuscularly in one hind limb of mice. After 24 hours, the mice were sacrificed and treated limbs collected, muscle weighed and counted
in a gamma counter. Data are expressed as the % of injected dose/100 mg (% ID/100 mg) of tissue. Each point is the average of 5 mice. Bars
represent standard deviation. Statistical analysis was performed by Student’s t test. ***p,0.001; *p,0.05. C,
111In-ST2210 was intravenously injected,
24 hours after the intramuscular administration of 15 ml of AvidinOX or indicated substances, at 3 mg/ml, in one hind limb of Balb/c mice. Mice were
sacrificed after 2 hours and pre-treated and contra lateral limbs muscle (average from all treated groups) weighed and counted in a gamma counter.
Data are expressed as the % of injected dose/g (% ID/g) of tissue. Each point is the average of 5 mice. Bars represent standard deviation. Statistical
analysis by Student’s t test. ***p,0.001. D, Confocal microscopy of PC3 cells incubated with the indicated products at 37uC as described in Materials
and Methods. Mounting medium (Vectashield, Vector) containing DAPI (H-1200) was used to stain nuclei. Each panel shows DAPI stained nuclei
(upper left), phase contrast image (upper right), staining with primary antibodies followed by second FITC-conjugated antibodies (lower left), merge
of DAPI and avidin/streptavidin staining (lower right).
doi:10.1371/journal.pone.0021075.g002
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oxidized streptavidin and oxidized low and high mannose
streptavidin were 1.6960.25, 3.5560.41 and 9.6861.16 % ID/
100 mg of tissue, respectively, compared to 19.1164.19 of
AvidinOX. Both low and high mannose streptavidin exhibited
a higher tissue residence compared to streptavidin, but interest-
ingly, their oxidized derivatives showed reduced (low mannose) or
equal (high mannose) tissue residence compared to their native
form (Fig. 2B). In parallel groups of mice the same products were
injected intramuscularly and, after 24 hours,
111In-biotinDOTA
(ST2210) was intravenously administered. The radioactivity
uptake in the limb treated with streptavidin, glycosylated
streptavidin or their oxidized derivatives was in any case lower
than 4 % ID/g of tissue as compared to about 16 % ID/g of
AvidinOX-treated limbs (Fig. 2C). In order to explain such lack
of uptake of radiolabeled biotin by the tissue resident glycosylated
streptavidin (oxidized or native) confocal microscopy was
performed on PC3 and NIH-3T3 cells incubated at 37uCw i t h
the indicated proteins in culture medium as described in
Materials and Methods. While AvidinOX was confirmed to
strongly bind PC3 cell membranes, a clear intra-cytoplasmic
localization of glycosylated and, to an apparent lower extent,
oxidized glycosylated streptavidin was observed (Fig. 2D). Native
avidin was also found inside the cells while native streptavidin was
undetectable (Fig. S1). Same results were obtained with NIH-3T3
cells (data not shown). Confocal experiments showed that
streptavidin, once mannosylated, is internalized by active
endocytosis (dead or damaged cells show negative cytoplasm)
indicating that the presence of sugars on such avidin like
tetramer, enhances cell binding and tissue residence as compared
to native streptavidin. However, confocal microscopy also clearly
indicated that while oxidized avidin strongly binds to cell
membranes, oxidized glycostreptavidin is actively translocated
inside the cells thus explaining the lack of biotin uptake in vivo.
Overall, the study indicates that the presence of sugars on a
tetrameric structure resembling the avidin quaternary organiza-
tion is necessary but not sufficient to explain the binding property
of AvidinOX.
Tissue residence and cell binding of oxidized
glycoproteins and acetylated avidin
To get a measure of the peculiarity of AvidinOX we extended
the evaluation of tissue residence and cell binding to three
additional oxidized glycoproteins namely PTX3 (multimeric, 10%
of complex sugars, pI 4.7) [11], HerceptinH (chimeric immuno-
globulin, 4% of complex sugars, pI 9.2) [12], carcinoembryonic
antigen, CEA (monomeric, 50–60% of complex sugars, pI 3–4)
[13] and found that none of them resided within injected tissues
nor bound to cells in vitro like AvidinOX despite high number of
aldehyde groups/glycoprotein (data not shown). We hypothesized
that such peculiar behaviour of oxidized avidin might correlate
with its uncommon high cationic charge. Therefore, to lower the
pI, avidin was acetylated by reaction with acetic acid N-
hydroxysuccinimide ester at 1:20, 1:40 and 1:80 molar ratios.
Isolectrofocusing analysis confirmed that 1:80 reaction reduced the
avidin pI to about 4.7 (Fig. 3A).
This acidic avidin was therefore oxidized as previously
described generating 15.1 aldehyde groups/glycoprotein and
tested for cell binding by cytofluorimetry. As shown in the
Fig. 3B the acetylated avidin lost the cell binding property of
native avidin while its oxidized derivative exhibited a lower
binding compared to oxidized avidin. In vivo data showed for the
acetylated and oxidized acetylated avidin a tissue residence,
24 hour after intramuscular injection, slightly higher than that of
native avidin but about 1/3 compared to oxidized avidin (Fig. 3C).
These data lead to the conclusion that the cationic charge is
relevant to the AvidinOX capacity to chemically link to cells and
tissues.
Protein and cell interaction analyses
To further investigate the avidin interaction with protein and
cellular substrates, we performed protein interaction analysis by
plasmon resonance and measured cellular impedance variations.
Biacore chip was coated with a mixture of tenascin and fibronectin
matrix proteins. A signal of about 300 Resonance Units (RU) was
observed with Tenatumomab (anti-tenascin monoclonal antibody)
[14], as expected. Avidin exhibited a non specific binding of about
30 RU while other proteins including the Rituximab (anti-CD20
monoclonal antibody) [15], streptavidin, glycosylated streptavidin,
ovalbumin and acetylated avidin did not give a detectable
resonance signal (Fig. 4, upper panel).
Concerning the oxidized derivatives, streptavidin (,2 aldehyde
groups/protein), ovalbumin (12.6 aldehyde groups/glycoprotein),
Acetylavidin (15.1 aldehyde groups/glycoprotein), GlyStreptavidin
(8.5 aldehyde groups/glycoprotein), Rituximab (29.9 aldehyde
groups/glycoprotein) and Tenatumomab (11.5 aldehyde groups/
glycoprotein), injected at neutral pH, which potentially allows the
formation of Schiff’s bases, did not show binding as the related
native forms. Surprisingly, more than 2000 RU signal was
observed with AvidinOX (16.5 aldehyde groups/glycoprotein)
indicating extensive linkage to the matrix proteins (Fig. 4, lower
panel). Such linkage was proved to be irreversible: in fact,
AvidinOX did not dissociate even after repeated attempts of chip
regeneration thus leading to the conclusion that formation of
highly stable Schiff’s bases between AvidinOX and matrix proteins
on the chip had occurred. The analysis was repeated on a new
coated chip at acidic pH at which matrix proteins are in the inert
protonated status. In this case avidin and AvidinOX gave a
measurable binding that was easily reversed by chip regeneration.
The system was then brought to neutral pH where the reversible
binding of avidin and Tenatumomab was observed, confirming
integrity of matrix proteins at low pH. As previously observed,
injection of AvidinOX at neutral pH, resulted in its irreversible
linkage to the coated chip thus confirming the occurrence of
Schiff’s bases (data not shown).
To evaluate the effect of interaction of avidin and AvidinOX
with cellular substrates we measured cellular impedance, a
parameter known to be strictly related to responses of the leaving
cells to different physico/chemical or mechanical stimuli [16].
Impedance analysis on PC3 cells indicated that the specific
lysophosphatidic acid (LPA) receptor agonist [17] induced, in the
11 minutes after addition, a reduction of the signal with an EC50
of 55.9 nM. Interestingly, avidin and AvidinOX induced an
increase of impedance with EC50 of 126.3 and 752.1 nM,
respectively. Acetylavidin and streptavidin had no significant effect
up to 10 mM (Fig. 5, upper panels).
These PC3 impedance results were confirmed on NIH-3T3 cells
where the specific receptor ligand platelet-derived growth factor
BB (PDGF-BB) [18] induced an impedance variation (increase of
the signal) with an EC50 of 0.62 nM while avidin and AvidinOX
induced also an increase of the signal with EC50 of 638 and
2134 nM, respectively. As for PC3, Acetylavidin and streptavidin
had no effect up to 10 mM (Fig. 5, lower panels). No significant
impedance variation on both cell lines was recorded with the
highly cationic lysozyme (pI.10) [19] (Fig. S2) suggesting that the
avidin cationic charge is necessary but not sufficient to explain
induction of impedance variation.
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Hen egg white avidin has high cationic charge (pI.10) and this
feature has been previously related to its non specific binding to
negatively charged proteins and cellular substrates and to tumor
accumulation [20] and the present in vitro and in vivo data are in
agreement with this observation. Nevertheless, we previously
showed that the tissue half life of avidin is less than two hours [2].
Here we show that acetylated avidin, exhibiting acidic charge
and not displaying basal binding to protein and cellular substrates,
binds much less than AvidinOX to cells and tissues once oxidized.
Present plasmon resonance data confirm the peculiar interaction
of avidin with proteins, resulting in an irreversible linkage of
AvidinOX but also indicate that binding is not a sufficient
condition to allow the formation of a stable linkage as
demonstrated by the reversibility of the binding of the oxidized
Tenatumomab. Finally, cellular impedance analyses showed that
avidin induces a clearly measurable change of electric potential
most likely a consequence of its electrostatic interaction with cell
membranes.
We might expect that other poultry avidins [21] as well as the
chicken avidin-related protein 4/5 [22] or frog Xenavidin [23], all
known to exhibit high cationic charge and structure similarity with
avidin, might behave like AvidinOX, after oxidation. On the other
Figure 3. In vitro binding and in vivo residence of acetylated avidin. A, Isoelectric focusing of acetylated avidin. Lane 1, IEF standards; Lane 2,
Herceptin, streptavidin and ovalbumin mixture; Lane 3, Acetylated avidin 1:80; Lane 4, Acetylated avidin 1:40; Lane 5, Acetylated avidin 1:20. B, Cells
were incubated with 150 mM avidin, AvidinOX, acetylated avidin pI 4.7 (Acetylavidin) or oxidized acetylated avidin (OxAcetylavidin) at +4uC and
binding revealed by cytofluorimetry with an anti-avidin antibody as detailed in Materials and Methods. Gray peaks are background (second antibody,
only). Thin and bold lines, native and oxidized glycoproteins, respectively. C, Avidin and acetylated avidin pI 4.7 (Acetylavidin), were
125I-labeled and
then oxidized with sodium periodate as described in Materials and Methods. All samples were diluted at 3.0 mg/ml in sodium acetate pH 5.5 and
15 ml were injected intramuscularly in one hind limb of mice. After 24 hours, the mice were sacrificed and treated limbs collected, weighed and
counted in a gamma counter. Data are expressed as the % of injected dose/100 mg (% ID/100 mg) of tissue. Each point is the average of 5 mice. Bars
represent standard deviation. Statistical analysis by Student’s t test. ***p,0.001.
doi:10.1371/journal.pone.0021075.g003
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Samples were injected in HBS at 1 mM and allowed to interact with immobilized mixture of human tenascin and fibronectin matrix proteins
(immobilization signal 4100RU) for 1 minute, then allowed to dissociate for 1 minute. Sensorgrams were obtained subtracting background signals of
the uncoated reference cell. Upper panel: Native proteins. Lower panel: Oxidized glycoproteins. Arrows indicate start and end of injection. Data are
representative of two experiments.
doi:10.1371/journal.pone.0021075.g004
Figure 5. Interaction of AvidinOX and others glycoproteins with cells by Cellular Impedance analyses. Impedance assays on PC3 and
NIH-3T3 cell lines by Cell KeyH technology. All samples were tested up to 10 mM concentration. Impedance variation was recorded for 11 minutes
after the addition of the samples. Background values were obtained from cells incubated with 0.1% BSA HBSS buffer and were subtracted from total
signal.
doi:10.1371/journal.pone.0021075.g005
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bradavidins [24;25] or rhizavidin [26] might be investigated to
further assess the role of protein charge and structure on the
behaviour of oxidized derivatives.
On the overall, present data point to AvidinOX as a peculiar
product whose in vivo property to link and reside within injected
tissues for weeks is clearly related to its cationic charge that, by
electrostatic interaction with negatively charged cellular mem-
branes and extracellular proteins, promotes the formation of
highly stable Schiff’s bases. The use of this product for the targeted
delivery of radiolabeled biotin will be clinically evaluated in the
next future supported by the good safety and tolerability data
obtained in rodents and non human primate studies [27].
Materials and Methods
Ethics Statement
The care and husbandry of the animals employed in the present
studies were in accordance with the European Directive 86/609
and Italian legislation. The animal studies described in the present
work were approved by the Italian Ministry of Health D.M. 137/
2010-B.
Periodate oxidation of avidin and other glycoproteins
Avidin (Tecnogen) was oxidized with 20mM sodium periodate
(NaIO4) (Sigma- Aldrich), in 100 mM acetate at pH 5.5 for 1 hour
at room temperature, in the presence of a molar excess of
4-hydroxyazobenzene-29-carboxylic acid (HABA) (Sigma-Aldrich)
and purified by chromatography on a Sephadex G-25 fine desalting
column (GE Healthcare) as previously reported [3]. Ovalbumin
(Sigma-Aldrich), pentraxin 3 (PTX3) (Tecnogen), CEA (US
biological) Tenatumomab (Sigma-Tau), Rituximab (Roche
Pharma) and HerceptinH (Roche) were oxidized (without HABA)
with periodate and purified by size exclusion chromatography as
described above for avidin. Glycosylated streptavidin was obtained
by reacting streptavidin with a-D-mannopyranosylphenylisothio-
cyanate (Sigma-Aldrich) at 1:25 molar ratio at +4uC for 5 or
24 hours and purified by size exclusion chromatography. The
degree of glycosylation was evaluated by estimating the residual
amino groups by reaction with 2,4,6-trinitrobenzene 1-sulfonic acid
(TNBS) according to standard method [28]. Avidin acetylation was
performed by reaction with acetic acid N-hydroxysuccinimide ester
(Sigma-Aldrich) according to a described method [29] and the
extent of amino group acetylation was determined by titration with
TNBS as before. Oxidation of glycosylated streptavidin (Glystrep-
tavidin) and acetylated avidin (Acetylavidin) was performed in the
presence of HABA as previously described for avidin. The number
of aldehyde groups (CHO) generated on the carbohydrate moieties
by oxidation, was evaluated according to a published method [30]
using PurpaldH reagent (Sigma- Aldrich) and propionaldehyde
diethyl acetal (Fluka)as a standard. Isoelectric point of glycoproteins
was evaluated by isoelectrofocusing on 3-10 IEF gel (Invitrogen).
Biotin binding capacity of strept/avidin and oxidized strept/avidin
derivatives was evaluated by HABA assay according to standard
method [31].
Cytofluorimetry
Reactivity of primary antibodies towards native and oxidized
glycoproteins was preliminary confirmed by ELISA. Cytofluori-
metry was performed on mouse fibroblast NIH-3T3 and human
prostate carcinoma PC3 cell lines (ATCC) after 1 hour incubation
at 4uC with native or oxidized glycoproteins (150 mM/5610
5 cells
in 100 mL of PBS). After washings, binding was revealed by
incubating cells for 1 hour at 4uC with the following specific
primary antibodies: mouse anti-avidin (Sigma-Aldrich), mouse
anti-ovalbumin (Sigma-Aldrich) followed by FITC-conjugated
goat anti-mouse Ig (Sigma-Aldrich); rabbit anti-streptavidin
(Sigma-Aldrich) followed by FITC-conjugated goat anti-rabbit Ig
(BD Pharmingen); rat anti-PTX3 monoclonal antibody (Alexis)
followed by FITC-conjugated goat anti-rat Ig (BD Pharmingen);
HerceptinH was revealed by FITC-conjugated mouse anti-human
Ig (BD Pharmingen). Analysis was performed on a FACScalibur
instrument and data elaborated by CellQuest software (Becton
Dickinson).
Confocal microscopy
Mouse fibroblast NIH-3T3 and human prostate carcinoma PC3
cell lines (1.0610
5) were plated on a coverglass and cultivated for
24 hours. Coverglasses were washed with serum free medium and
incubated with 150 mM AvidinOX or oxidized glycosylated
streptavidin or their related controls (native avidin, native
streptavidin, glycosylated streptavidin) for 2 hours at 37uCi n
serum free medium. After washings with PBS, cells were fixed with
4% paraformaldehyde for 15 minutes at room temperature,
washed with PBS, blocked with PBS, 1% BSA and incubated
1 hour at room temperature with primary anti-avidin or anti-
streptavidin antibodies. After washings with PBS, coverglasses
were incubated with FITC-conjugated second antibodies for
1 hour at room temperature as previously described for cyto-
fluorimetry. After washings, coverglasses were observed at
confocal microscopy Zeiss LSM 700.
In vivo studies
Radiolabeling of all proteins was performed with
125Iodine by
IODO-GEN
TM (Pierce) before periodate oxidation. Radiolabeled
compounds, formulated in 0.1 M sodium acetate pH 5.5, were
injected in one hind limb muscle at the dose of 50 mgi n1 5ml
(about 50 kBq/mouse). At the indicated time points mice were
sacrificed and the injected muscle weighed and radioactivity
quantified by gamma counter. Each sample was referred to the
injected dose that was re-counted at each time point to take into
account radioactive decay. For the intra-tissue administration,
data were expressed as the % of injected dose/100 mg of tissue (%
ID/100 mg) to avoid values .100% being the treated muscle
,1 g. The biotin-DOTA ST2210 (Sigma-Tau) was labelled with
111Indium according to the previously published method [32]. For
uptake experiments, groups of mice were pre-treated with oxidized
strept/avidin or strept/avidin in one hind limb and then injected
intravenously, at the indicated time points, with 1 mgo f
111In-
ST2210 (about 300 kBq/mouse) in 200 ml of vehicle. Mice were
sacrificed 2 hours after
111In-ST2210 injection and pre-treated
limbs weighed and radioactivity quantified by gamma counter.
Data were expressed as % ID/g of tissue.
Plasmon resonance analysis
The interaction of glycoproteins and their related oxidized
derivatives with matrix proteins was analyzed by BIAcore X (GE
Healthcare). The CM4 sensor chip was prepared by immobilizing
a mixture of human tenascin and human fibronectin (Tecnogen)
through primary amino groups using amine coupling kit according
to manufacturer’s instruction (BIAcore AB). Immobilization gave a
DRU=4100. Each binding assay was performed in HBS (10 mM
HEPES, 150 mM NaCl, 3 mM EDTA, 0.05% BIAcore surfactant
P20 at pH 7.4) at the constant flow rate of 5 ml/minute, 25uC.
Glycoproteins in their native and oxidized forms were injected at
1 mM concentration in HBS for 1 minute and then allowed to
dissociate for 1 minute followed by regeneration of the sensor chip
by a pulse of 0.1M NaOH. Sensorgrams were obtained by
In vivo Chemical Conjugation of AvidinOX
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and by elaboration with the BIAevaluation 4.1.1 software.
Cell KeyH analysis
Impedance assay was performed on PC3 and NIH-3T3 cells by
using the Cell KeyH technology (Cerep). Briefly, 3610
4 PC3 or
4610
4 NIH-3T3 cells were plated in 96 well microtiter plates and
grown for 24 hours. Culture medium was then replaced by 0.1%
BSA HBSS buffer added with the specific binders LPA (Sigma-
Aldrich) or PDGF/BB (Sigma- Aldrich) for PC3 and NIH-3T3
cells, respectively or with serial dilution of avidin, AvidinOX,
Acetylavidin (pI 4.7), streptavidin (BioSPA) or lysozyme (Sigma-
Aldrich).
Statistics
The results are expressed as mean 6 S.D. Differences between
groups were assessed using unpaired two-tailed Student’s t-test or
two-way analysis of variance (ANOVA) (factors of variance were
dose and days of treatment). When normality test failed, it was
used Kruskal-Wallis one-way analysis of variance on ranks
(ANOVA on ranks). When the ANOVA manifested a statistical
difference, all pairwise multiple comparison procedures (Dunnett’s
or Student- Newman-Keuls test) were applied. The p,0.05 value
was considered to be significant in all experiments. Analysis of data
and plotting of the figures were done with the aid of softwares
(SigmaStat and SigmaPlot, Version 5.0, San Raphael, CA, USA;
GraphPad PRISMH, Version 2.0, San Diego, CA, USA; Microsoft
Excel 2003, Redmond, WA, USA).
Supporting Information
Figure S1 onfocal microscopy of PC3 cells incubated
with avidin or streptavidin. PC3 cells were incubated at 37uC
with 150 mM of either avidin or streptavidin in culture medium as
described in Materials and Methods. After processing, mounting
medium (Vectashield, Vector) containing DAPI (H-1200) was used
to stain nuclei. The four panels show: DAPI stained nuclei (upper
left), phase contrast image (upper right), staining with primary
antibodies followed by second FITC-conjugated antibodies (lower
left), merge of DAPI and avidin/streptavidin staining (lower right).
(TIF)
Figure S2 Impedance assays on PC3 and 3T3 cell lines
incubated with lysozyme. Lysozyme was tested up to 10 mM
concentration. Impedance variation (Cell KeyH technology) was
recorded for 11 minutes after the addiction of the sample.
Background values were obtained from cells incubated with 0.1%
BSA HBSS buffer and were subtracted from total signal.
(DOC)
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